Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to support NHS Trusts with (a) additional pharmacist staff salaries, (b) the cost of additional monitoring blood tests and (c) additional service delivery costs when new drug treatments are funded for NHS patients.

The 2025/26 NHS Payment Scheme, published on 4 April 2025, governs transactions between providers and commissioners of secondary healthcare by setting the rules for determining the amount payable for the provision of healthcare services. In short, it defines the basis for fairly reimbursing National Health Service trusts for the work they do. More information on the scheme is available at the following link:

https://www.england.nhs.uk/long-read/25-26-nhs-payment-scheme/

Prices in the scheme have been updated to reflect the latest NHS pay awards. The 2025/26 prices have been calculated in part by updating 2024/25 pay award prices, published in September 2024. for inflation and efficiency;

The scheme includes a published list of 2025/26 prices reflecting the latest pay awards, which are available at the following link:

https://www.england.nhs.uk/publication/2025-26-nhs-payment-scheme/

This list includes the price paid to NHS trusts for persons who solely require a blood test. High-cost drugs, which can include those that have just received approval, are excluded from prices and are subject to separate agreement on appropriate funding between providers and commissioners.